Why the study?
ICU discharge decisions carry risks of unnecessary prolonged stays or readmissions that are associated with adverse outcomes, necessitating decision-making systems to predict readmissions.
Does a LightGBM classifier improve the prediction of ICU readmission within three days compared to other machine learning classifiers in ICU patients?
Does a LightGBM classifier improve the prediction of ICU readmission within three days compared to other machine learning classifiers in ICU patients?
A LightGBM classifier using electronic health record data can predict ICU readmission within 3 days with an AUC of 78.6%, offering a potentially more accurate approach to identifying high-risk patients.
Answers are grounded in this paper and cite their sources.
May enhance early ICU readmission risk stratification; leaves open prospective validation before clinical use.
Decision to discharge a patient from an intensive care unit (ICU) is difficult, with a risk of prolonging unnecessarily the stay and a risk of ICU readmission, which is associated with adverse outcomes. We propose to use light gradient boosting (lightGBM) classifier to build decision-making systems to predict which patients are most likely to experience ICU readmission within the first three days. The classifier was developed and tested using MIMICIII database. We extracted many clinical data from the electronic health records (EHR) stored in MIMICIII database. Then, several statistical, temporal and spectral features were extracted. In addition, some feature selection methods were used to select the most informative data. The performance of our LightGBM classifier is superior to the previously tested machine learning (ML) classifiers, as evidenced by an area under the curve (AUC) of 78.6%. The development of our prediction model for ICU readmission offers a more accurate approach to identifying patients at high risk, potentially reducing readmission rates and improving patient outcomes.
No takes yet. Share an insight, caveat, or question.
Fathy et al. (2023) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: